NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000005096

Registered date:01/03/2011

11C-methionine PET for diagnoses of lung cancer and lymph node metastases in the mediastinum and pulmonary hilum: probability of prognostic prediction

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedlung cancer
Date of first enrollment2009/04/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)To scan PET-CT after administering intravenously 11C-methionine in patients with lung cancer.

Outcome(s)

Primary OutcomeThe assessment of our study is to calculate SUVmax of primary lesion and lymph node metastasis on 11C-MET-PET, correlating with morphological evaluation using CT and histopathological evaluation.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criterianot getting informed consent from patients

Related Information

Contact

public contact
Name Jun Hatazawa
Address 2-2, Yamadaoka, Suita, Japan Japan
Telephone 06-6879-3461
E-mail hatazawa@tracer.med.osaka-u.ac.jp
Affiliation Osaka university graduate school of medicine Nuclear medicine
scientific contact
Name Jun Hatazawa
Address 2-2, Yamadaoka, Suita, Japan Japan
Telephone 06-6879-3461
E-mail hatazawa@tracer.med.osaka-u.ac.jp
Affiliation Osaka university graduate school of medicine Nuclear medicine